2028年までのアジア太平洋地域のウイルス様粒子市場予測 - 製品タイプ別(肝炎、がん/HPV、ゴーシェ病)、発生源(酵母、昆虫細胞、植物など)、用途別(ワクチン)による新型コロナウイルス感染症の影響と地域分析および治療)

TIPRE00026817 | Pages: 125 | Pharmaceuticals | Jan 2022 | Type: Regional | Status: Published

アジア太平洋地域のウイルス様粒子市場 は、2021 年の 10 億 1,883 万 百万米ドルから 1,769.02 米ドルに成長すると予想されています2028 年までに 100 万人に達します。 2021 年から 2028 年にかけて 8.2% の CAGR で成長すると推定されています。

ヘルスケア市場のさまざまなプレーヤーや研究機関が製品の革新と開発に積極的に関わっています。ウイルス様粒子の使用は、バイオ医薬品業界で使用される新たなアプローチです。ウイルス様粒子にはウイルス成分が含まれていないため、実際のウイルス成分よりも扱いが容易です。 VLP は、ドラッグデリバリー、イメージング、免疫療法、および治療の補助に使用できます。例えば、2020年6月にNCBIに発表された研究によれば、VLPは光熱療法、PETおよびCTイメージング、MRI造影剤担体、光学イメージング、炎症性および自己免疫疾患ワクチン、がん免疫療法、および小分子薬物送達(がん治療における)。したがって、このような VLP の潜在的な応用は、予測期間中に市場関係者に成長の機会を提供すると予想されます。

 

国際通貨基金 (IMF) の報告書によると、 , アジア太平洋地域の成長は、2020年もゼロパーセントで停滞すると予想されていた。これは、世界金融危機(4.7%)とアジア金融危機(1.3%)を伴う約60年間で最悪の成長実績となった。韓国の場合は3.5%から下方修正が大幅にあったが、オーストラリア、ニュージーランド、タイでは9%を占める長期にわたる生産停止が最小限に抑えられたため、コロナウイルスの緩やかな感染拡大になんとか対処しているようだ。これらの国は世界的な観光業の停止と、オーストラリアの場合は一次産品価格の下落により大きな打撃を受けた。現在、新型コロナウイルス感染症ワクチンの開発が進められているアジア太平洋地域には、韓国、中国、日本、タイ、ベトナムが含まれる。このうち中国は15種類、インドと韓国は3種類、日本は2種類、タイとベトナムは1種類のワクチンを保有している。これらのワクチンの中には、10 種類の不活化ワクチン、6 種類のタンパク質サブユニットワクチン、7 種類のウイルスベクターワクチン、および 6 種類の核酸ワクチンが含まれます。さらに、安全で公平かつ効果的なワクチンの推進は、アジア太平洋地域における最優先事項です。アジア開発銀行の報告書によると、2020年12月、アジア開発銀行(ADB)はアジア太平洋ワクチンアクセスファシリティ(APVAX)と共同で90億ドル規模のワクチン構想を立ち上げ、発展途上の加盟国に迅速かつ公平な支援を提供することになった。各国(DMC)が効果的で安全な新型コロナウイルス感染症ワクチンを調達し、提供することを目的としています。ワクチン接種を通じて、ウイルス感染の連鎖を断ち切り、命を救い、パンデミックによる悪影響を軽減することができます。

 

機能やテクノロジーを活用することで、ベンダーは新規顧客を獲得し、新興市場での拠点を拡大することができます。この要因は、アジア太平洋地域のウイルス様粒子市場を牽引する可能性があります。アジア太平洋地域のウイルス様粒子市場は、予測期間中に良好な CAGR で成長すると予想されます。

 

 アジア太平洋地域のウイルス様粒子市場の収益と 2028 年までの予測 (百万米ドル)

 

アジア太平洋地域のウイルス様粒子市場セグメンテーション

 

アジア太平洋地域のウイルス様粒子市場 –製品タイプ別

  • 肝炎
  • がん/HPV
  • ゴーシェ病

アジア太平洋のウイルス様粒子市場 –ソース別

  • 酵母
  • 昆虫細胞
  • 植物
  • その他

アジア太平洋のウイルス様粒子市場 – アプリケーション

  • ワクチン
  • 治療

アジア太平洋地域のウイルス様粒子市場 –

  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • その他のアジア太平洋地域     

アジア太平洋地域のウイルス様粒子市場 –言及された企業

  • Merck &株式会社                        ;                       &nバスプ;       
  • GlaxoSmithKline plc.
  • ファイザー株式会社  ;                       &nバスプ;                               ;              
  • サノフィ                                ;                           ;                    
  • <スパン>セラム インスティテュート オブ インド プライベート株式会社                            
  • BHARAT BIOTECH               ;                       &nバスプ;               
  • LG 化学                             ;                           ;                 
  • ワンタイ バイオファームスパン>

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Virus-like Particles Market – By Product Type

1.3.2        Asia Pacific Virus-like Particles Market – By Source

1.3.3        Asia Pacific Virus-like Particles Market – By Application

1.3.4        Asia Pacific Virus-like Particles Market – By Country

2.           Asia Pacific Virus-like Particles Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Virus-like Particles Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Experts Opinion

5.           Asia Pacific Virus-like Particles Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Surging Prevalence of Infectious Viral Diseases

5.1.2        Increasing Role of Virus-Like Particles in Therapeutic Developments and Studies

5.2         Market Restraints

5.2.1        Reach of Alternative Technologies for Viral Vaccine Production

5.3         Market Opportunities

5.3.1        Growing Potential Applications in Therapeutics and Diagnostics

5.4         Future Trends

5.4.1        Steady Demand for Innovative and Effective Products

5.5         Impact Analysis

6.           Asia Pacific Virus-like Particles Market Analysis

6.1         Asia Pacific Virus-like Particles Market Revenue Forecast and Analysis

7.           Asia Pacific Virus-like Particles Market Analysis – by Product Type

7.1         Overview

7.2         Asia Pacific Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

7.3         Hepatitis

7.3.1        Overview

7.3.2        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.4         Cancer/ Human Papillomavirus (HPV)

7.4.1        Overview

7.4.2        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.5         Gaucher Disease

7.5.1        Overview

7.5.2        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.           Asia Pacific Virus-like Particles Market Analysis – By Source

8.1         Overview

8.2         Asia Pacific Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

8.3         Yeast

8.3.1        Overview

8.3.2        Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.4         Plant

8.4.1        Overview

8.4.2        Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.5         Insect Cell

8.5.1        Overview

8.5.2        Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.           Asia Pacific Virus-like Particles Market Analysis – By Application

9.1         Overview

9.2         Asia Pacific Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

9.3         Vaccines

9.3.1        Overview

9.3.2        Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.4         Therapeutics

9.4.1        Overview

9.4.2        Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.        Asia Pacific Virus-like Particles Market – Country Analysis

10.1      Overview

10.1.1     Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

10.1.1.1       Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.1.1.2       Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3       Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)

10.1.1.1.4       Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

10.1.1.1.5       Japan Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2       China: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1       Overview

10.1.1.2.2       China: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3       China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.4       China: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

10.1.1.2.5       China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3       India Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Overview

10.1.1.3.2       India: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.4       India Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.5       India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4       South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1       Overview

10.1.1.4.2       South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3       South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.4       South Korea Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.5       South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.5       Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1       Overview

10.1.1.5.2       Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.3       Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.4       Australia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.5       Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.6       Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1       Overview

10.1.1.6.2       Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3       Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.4       Rest of Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.5       Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

11.        Impact Of COVID-19 Pandemic on Asia Pacific Virus-like Particles Market

11.1      Impact Assessment of COVID-19 Pandemic

12.        Asia Pacific Virus-like Particles Market–Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Merck & Co., Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      GlaxoSmithKline plc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Pfizer Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Sanofi

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Wantai BioPharm

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Serum Institute of India Pvt. Ltd.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      BHARAT BIOTECH

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      LG Chem

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             Asia Pacific Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)

Table 2.             Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)

Table 3.             Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

Table 4.             Japan Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 5.             China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 6.             China: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

Table 7.             China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 8.             India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 9.             India Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 10.          India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 11.          South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 12.          South Korea Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 13.          South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 14.          Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 15.          Australia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 16.          Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 17.          Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 18.          Rest of Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 19.          Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 20.          Organic Developments Done by Companies

Table 21.          Inorganic Developments Done by Companies

Table 22.          Glossary of Terms: Virus-like Particles Market

 


LIST OF FIGURES

Figure 1.           Asia Pacific Virus-like particles Market Segmentation

Figure 2.           Asia Pacific Virus-like particles Market Segmentation, By Country

Figure 3.           Asia Pacific Virus-like Particles Market Overview

Figure 4.           Hepatitis Held the Largest Share of the Product Type Segment in Asia Pacific Virus-like particles Market

Figure 5.           India to Show Significant Growth during Forecast Period

Figure 6.           Asia Pacific Virus-like Particles Market, Industry Landscape

Figure 7.           Asia Pacific PEST Analysis

Figure 8.           Asia Pacific Virus-like Particles Market: Impact Analysis of Drivers and Restraints

Figure 9.           Asia Pacific Virus-like Particles Market– Revenue Forecast and Analysis to 2028

Figure 10.        Asia Pacific Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

Figure 11.        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Asia Pacific Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

Figure 15.        Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        Asia Pacific Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

Figure 20.        Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Therapeutics: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        Asia Pacific Virus-like Particles Market Overview, by Country (2021)

Figure 23.        Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

Figure 24.        Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 25.        China: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 26.        India: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 27.        South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Impact of COVID-19 Pandemic in Asia Pacific Country Markets

  1. Merck & Co., Inc.                                                       
  2. GlaxoSmithKline plc.                                                
  3. Pfizer Inc.                                                                    
  4. Sanofi                                                                         
  5. Serum Institute of India Pvt. Ltd.                           
  6. BHARAT BIOTECH                                                      
  7. LG Chem                                                                     
  8. Wantai BioPharm
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific virus-like particles market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific virus-like particles market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the virus-like particles market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000